one way or another I believe PYC can achieve the seemingly impossible. Even if they can translate the mouse models to patient derived models/NHP it’ll rock the boat.
If we have the better shot for curing such a horrible disease as ALS, then let us have a shot at brining hope to those suffering.
Hopefully we can get around this block somehow - if we still have the best cargo carrier; is it then a matter of switching out the cargo with a different mechanism of tackling the cellular type, or are we blocked from dabbling in this area completely?
PYC, page-48
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.0¢ | $297.5K | 2.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1372418 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 390472 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |